References
- Craighead J E, Gibbs A R, editors. (2008). Asbestos and Its Diseases. Oxford University Press, New York.
- Gibbs A R. (1990). Role of asbestos and other fibres in the development of diffuse malignant mesothelioma. Thorax. 45(9):649–654.
- Gilks B. Hegedus C, Freeman H, et al. (1988). Malignant peritoneal mesothelioma after remote abdominal radiation. Cancer. 61:2019–2021.
- Hillerdal G, Berg J. (1985). Malignant mesothelioma secondary to chronic inflammation and old scars. Cancer. 55:1968–1972.
- Ilgren E B, Wagner J C. (1991). Background incidence of mesothelioma: Animal and human evidence. Regul Toxicol Pharmacol. 13(2):133–149.
- Kerrigan S, Turnnir R, Clement P, et al. (2002). Diffuse malignant epithelial mesotheliomas of the peritoneum in women: A clinicopathologic study of 25 patients. Cancer. 94:378–385.
- Kerrigan S, Cagle P, Churg A. (2003). Malignant mesothelioma of the peritoneum presenting as an inflammatory lesion: A report of four cases. Am J Surg Pathol. 27(2):248–253.
- Lane, Frederic C. (2001). Ships for Victory, A History of Shipbuilding Under the U.S. Maritime Commission in World War II. Johns Hopkins University, Baltimore, MD (original publication in 1951).
- Lerman Y, Learman Y, Schachter P, et al. (1991). Radiation associated with malignant pleural mesothelioma. Thorax. 46:463–464.
- McDonald J C. (1985). Health Implications of environmental exposure to asbestos. Environ Health Perspect. 62:319–328.
- McDonald J C., McDonald A D. (1996). The epidemiology of mesothelioma in historical context. Eur Respir J. 9:1932–1942.
- Moolgavkar SH, Meza R, Turim J. (2009). Pleural and peritoneal mesotheliomas in SEER: Age effects and temporal trends, 1973–2005. Cancer Causes Control. March 18.
- NIOSH WORLD Work Related Lung Disease Report for Mesothelioma. (2007). http://www2.cdc.gov/drds/WorldReportData/FigureTableDetails.asp?FigureTableID=900
- NORMS. (2008). National Occupational Respiratory Mortality System. http://webappa.cdc.gov/ords/norms.html
- NCHS Death Rates. National Center for Health Statistics. Death Rates for Selected Causes by 1 0-Year Age Groups, Race, and Sex: Death Registration States, 1900-32, and United States, 1933-98. http ://www.cdc.gov/nchs/datawhlstatab/unpubd/mortabs/hist290a.htm
- Peterson JT, Greenberg DS, Buffler PA. (1984). Non-asbestos-related malignant mesothelioma: A review. Cancer. 54:951–960.
- Peto J, Henderson B E, Pike M C. (1981). Trends in mesothelioma incidence in the United States and the forecast epidemic due to asbestos exposure during World War II. Banbury Report 9: Quantification of Occupational Cancer. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 51–69.
- Polednak A P. (2003). Geographic distribution of incident mesothelioma in Connecticut men, 1990–99. Int J Cancer. 107, 509–510.
- Price B, Ware A. (2004). Mesothelioma trends in the United States: An update based on Surveillance, Epidemiology & End Results program data for 1973 through 2003. Am J Epidemiol. 159:107–112.
- SEER. (2008). Surveillance, Epidemiology, and End Results Program (www.seer.cancer.gov ) SEER*Stat Database: Incidence—SEER 9, 13, 17 Registries Limited-Use, November 2007 Submission (1973–2005) Total U.S., 1969–2005 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on the November 2007 submission.
- SEER/NCI. (2007, November). Email to [email protected] to request county mortality data grouped by years. http://seer.cancer.gov/seerstat
- SEER registries discussion. (2008). Bethesda, MD: National Cancer Institute, Division of Cancer Control & Population Sciences, Surveillance Research Program. http://seer.cancer.gov/registries
- SEER*Stat Database: Mortality - All COD, Public-Use With State, Total U.S. (1969–2000), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2003. Underlying mortality data provided by NCHS (www.cdc.gov/nchs ).
- Spirtas R, Heineman E F, Bernstein L, et al. (1994). Malignant mesothelioma: Attributable risk of asbestos exposure. Occup Environ Med. 51:804–811.
- State Cancer Registry of Connecticut. (2008). http://www.cancer-rates.info/ct and http://www.ct.gov/dph/cwp/view.asp?a=3129&q=389716
- Teta J, Lau E, Sceurman B, Wagner M. (2007). Therapeutic radiation for lymphoma: Risk of malignant mesothelioma. Cancer. 109(7):1432–1438.
- Teta MJ, Mink PJ, Lau E, Sceurman BK, Foster ED. (2008). US mesothelioma patterns 1973–2002: Indicators of change and insights into background rates. Eur J Cancer Prev. 17(6):525–534.
- Travis L, Fossa S, Schonfeld S, et al. (2005). Second cancers among 40576 testicular cancer patients: Focus on long-term survivors. J Natl Cancer Inst. 97:1354–1365.
- Tward J, Wendland M, Shrieve D, et al. (2006). The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. Cancer. 107:108–115.
- U.S. Census Bureau, Population Division. (2005). Interim State Population Projections. Internet release date: April 21, 2005. Table 1: Interim Projections: Ranking of Census 2000 and Projected 2030 State Population and Change: 2000 to 2030.
- Wun LM, Merrill RM, Feuer EJ. (1998) Estimating lifetime and age- conditional probabilities of developing cancer. Lifetime Data Analysis; 4: 169–86.
- Weill H, Hughes JM, Churg AM. (2004). Changing trends in US mesothelioma incidence. Occup Environ Med. 61(5):438–441.